We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+0.34%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$400B
AUM Growth
-$39B
Cap. Flow
-$30.4B
Cap. Flow %
-7.6%
Top 10 Hldgs %
20.04%
Holding
8,359
New
534
Increased
2,613
Reduced
3,823
Closed
480

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.03B
2
PEP icon
PepsiCo
PEP
+$899M
3
CSX icon
CSX Corp
CSX
+$693M
4
AZO icon
AutoZone
AZO
+$632M
5
BMO icon
Bank of Montreal
BMO
+$430M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.16B
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$2.21B
3
AAPL icon
Apple
AAPL
+$1.76B
4
JPM icon
JPMorgan Chase
JPM
+$1.36B
5
TJX icon
TJX Companies
TJX
+$1.26B

Sector Composition

Rank Sector Weight
1 Financials 20.49%
2 Technology 12.97%
3 Healthcare 7.94%
4 Industrials 7.62%
5 Communication Services 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFI
7101
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$6K ﹤0.01%
5,378
-14,306
-73% -$17.1K
HARP
7102
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$6K ﹤0.01%
115
-328
-74% -$17K
BGRY
7103
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$6K ﹤0.01%
2,176
+1,792
+467% +$6.38K
EQOP
7104
DELISTED
Natixis U.S. Equity Opportunities ETF
EQOP
$6K ﹤0.01%
+200
New +$6.51K
EOCW.WS
7105
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$6K ﹤0.01%
+10,000
New +$7.49K
CDAK
7106
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$6K ﹤0.01%
978
-2,605
-73% -$16.4K
SGHC.WS
7107
DELISTED
Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share
SGHC.WS
$6K ﹤0.01%
+2,000
New +$3.5K
STRY
7108
DELISTED
Starry Group Holdings, Inc.
STRY
$6K ﹤0.01%
+717
New +$6.2K
EDNCW
7109
DELISTED
Endurance Acquisition Corp. Warrant
EDNCW
$6K ﹤0.01%
+22,827
New +$8.04K
SLHG
7110
DELISTED
Skylight Health Group Inc Common Shares
SLHG
$6K ﹤0.01%
5,259
-356
-6% -$359
RDBX
7111
DELISTED
Redbox Entertainment Inc. Class A Common Stock
RDBX
$6K ﹤0.01%
+2,631
New +$9.16K
EVFM
7112
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$6K ﹤0.01%
1,233
+1,200
+3,636% +$7.55K
WTRU
7113
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
0
REV
7114
DELISTED
Revlon, Inc.
REV
$6K ﹤0.01%
686
-931
-58% -$8.9K
AMPY icon
7115
Amplify Energy
AMPY
$200M
$5K ﹤0.01%
917
-695
-43% -$3.21K
ANNX icon
7116
Annexon
ANNX
$862M
$5K ﹤0.01%
1,915
-4,059
-68% -$25K
BBAI icon
7117
BigBear.ai
BBAI
$1.6B
$5K ﹤0.01%
+649
New +$3.97K
BCAB icon
7118
BioAtla
BCAB
$5.73M
$5K ﹤0.01%
19
-46
-71% -$19.2K
BCLI
7119
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$5K ﹤0.01%
102
BDTX icon
7120
Black Diamond Therapeutics
BDTX
$116M
$5K ﹤0.01%
1,771
-3,215
-64% -$11.7K
BKSE icon
7121
BNY Mellon US Small Cap Core Equity ETF
BKSE
$90.5M
$5K ﹤0.01%
174
+99
+132% +$2.96K
CINT icon
7122
CI&T Inc
CINT
$474M
$5K ﹤0.01%
+298
New +$4.36K
CLNN icon
7123
Clene
CLNN
$53.5M
$5K ﹤0.01%
63
-153
-71% -$9.26K
HELP
7124
Cybin Inc
HELP
$710M
$5K ﹤0.01%
143
+72
+101% +$2.63K
EEX
7125
DELISTED
Emerald Holding
EEX
$5K ﹤0.01%
1,447
-3,795
-72% -$13.2K

Similar funds

Royal Bank of Canada's Q1 2022 Portfolio in Review

As of Q1 2022, Royal Bank of Canada held 8,359 positions worth $400B, down 8.9% from $439B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada withdrew a net $30.4B in Q1 2022, closing 480 positions and reducing 3,823 holdings. Its most notable exit was Kirkland Lake Gold Ltd Ordinary, an estimated $413M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Royal Bank of Canada opened a new position in Shell worth $197M.

  • Royal Bank of Canada's largest Q1 2022 buy was Shell: 3,594,099 shares worth $197M.
  • Royal Bank of Canada added most to Charles Schwab in Q1 2022, an estimated $1.03B increase.
  • Royal Bank of Canada's biggest Q1 2022 reduction was Microsoft, cutting an estimated $3.16B.
  • Royal Bank of Canada fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $413M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $400B portfolio in Q1 2022.
  • Royal Bank of Canada opened 534 new positions and closed 480 in Q1 2022.
  • Royal Bank of Canada's portfolio value fell 8.9% quarter-over-quarter to $400B.

Based on Royal Bank of Canada's 13F filing for Q1 2022, filed 16 May 2022.